Posted by admin on Aug 3rd, 2022

Victory Capital Management Inc. grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 4.7% in the first quarter, HoldingsChannel reports. The institutional investor owned 818,401 shares of the medical instruments supplier’s stock after buying an additional 36,811 shares during the period. Victory Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $32,750,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. SOA Wealth Advisors LLC. raised its holdings in shares of DENTSPLY SIRONA by 26,666.7% in the first quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier’s stock worth $39,000 after buying an additional 800 shares during the last quarter. National Bank of Canada FI purchased a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $55,000. Dixon Hughes Goodman Wealth Advisors LLC purchased a new position in shares of DENTSPLY SIRONA in the first quarter worth $79,000. Covestor Ltd purchased a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $90,000. Finally, CWM LLC purchased a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $122,000. Hedge funds and other institutional investors own 94.79% of the company’s stock.

XRAY has been the subject of a number of research analyst reports. Piper Sandler decreased their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 in a report on Monday, July 11th. Robert W. Baird cut shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and reduced their target price for the stock from $67.00 to $48.00 in a report on Tuesday, April 19th. HC Wainwright reduced their target price on shares of DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating for the company in a report on Friday, April 22nd. UBS Group raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $58.00 to $47.00 in a report on Wednesday, June 1st. Finally, Bank of America cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $66.00 to $49.00 in a report on Tuesday, April 19th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus price target of $48.11.

Shares of NASDAQ XRAY opened at $35.57 on Wednesday. The company’s 50-day simple moving average is $36.74 and its 200-day simple moving average is $44.26. DENTSPLY SIRONA Inc. has a 52-week low of $33.78 and a 52-week high of $66.98. The firm has a market cap of $7.66 billion, a price-to-earnings ratio of 21.05, a price-to-earnings-growth ratio of 2.91 and a beta of 0.91. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The business had revenue of $9.67 billion for the quarter, compared to analyst estimates of $982.05 million. During the same quarter last year, the business earned $0.72 earnings per share. The company’s revenue for the quarter was up 841.1% compared to the same quarter last year. Equities analysts predict that DENTSPLY SIRONA Inc. will post 2.41 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, July 8th. Investors of record on Friday, June 24th were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, June 23rd. This represents a $0.50 dividend on an annualized basis and a yield of 1.41%. DENTSPLY SIRONA’s payout ratio is presently 29.59%.

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

HSBC (NYSE:HSBC) Shares Gap Up to $31.40

Activision Blizzard, Inc. (NASDAQ:ATVI) Holdings Lowered by Envestnet Asset Management Inc.